How unpopular is Swiss dental device company Nobel Biocare (NBHGY.PK)?
The stock was down 30% in 2012 and is down 75% over the past three
years, but the stock still carries an overwhelming number of "Sell"
recommendations. While Nobel has seen some significant negative
developments in its core dental implants market, it's still worth asking
whether this stock may not carry some value for risk-tolerant
deep-value turnaround investors.
Please click below for more:
Nobel Biocare Has Gotten Its Teeth Kicked In
No comments:
Post a Comment